Back to LCTX
VANGUARD PORTFOLIO MANAGEMENT LLC → LCTX
VANGUARD PORTFOLIO MANAGEMENT LLC LCTX Position History
Lineage Cell Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$197.5M
Q3 2026
Peak value
$248M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $186.7M |
| Q2 2026 | $248M |
| Q2 2026 | $1.7M |
| Q3 2026 | $1.2M |
| Q3 2026 | $197.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $197.5M | 5.79M | — | — |
| Q3 2026 | $1.2M | 1.30M | — | — |
| Q2 2026 | $1.7M | 1.27M | — | — |
| Q2 2026 | $248M | 5.73M | — | — |
| Q1 2026 | $186.7M | 5.70M | — | — |
Other funds holding LCTX
$668.6M
$601.9M
$537.7M
$532.4M
$482.3M
$391.7M
$332.9M
$299.1M